News & Updates

Vaginal lasers confer little to no benefit on women with stress urinary incontinence (SUI), as measured by clinical assessment in the short term relative to sham, control, or topical treatments, reports a study.

Results from the phase III PIVOT-PO study demonstrate the potential of tebipenem pivoxil hydrobromide (TBP-PI) as an effective oral carbapenem antibiotic for the treatment of complicated urinary tract infections (cUTI).

A recent study suggests a positive association between shift work and risk of kidney stone events, with lifestyle factors partially mediating the association.

In the final overall survival (OS) analysis of the phase III EMBARK trial, the combination of enzalutamide and androgen deprivation therapy (ADT; leuprolide acetate) delivers a significant OS benefit in men with high-risk biochemically recurrent (hrBCR) prostate cancer without evidence of metastases on conventional imaging.